nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—type 2 diabetes mellitus—metabolic syndrome X	0.481	0.583	CtDrD
Irbesartan—hypertension—metabolic syndrome X	0.344	0.417	CtDrD
Irbesartan—Seasonal allergy—Metformin—metabolic syndrome X	0.0055	0.0881	CcSEcCtD
Irbesartan—Rhinitis seasonal—Metformin—metabolic syndrome X	0.00528	0.0846	CcSEcCtD
Irbesartan—Distention—Metformin—metabolic syndrome X	0.00489	0.0784	CcSEcCtD
Irbesartan—Abnormal faeces—Metformin—metabolic syndrome X	0.00404	0.0646	CcSEcCtD
Irbesartan—JUN—artery—metabolic syndrome X	0.00369	0.106	CbGeAlD
Irbesartan—JUN—endothelium—metabolic syndrome X	0.00312	0.0894	CbGeAlD
Irbesartan—JUN—blood vessel—metabolic syndrome X	0.00287	0.0824	CbGeAlD
Irbesartan—AGTR1—artery—metabolic syndrome X	0.00278	0.0797	CbGeAlD
Irbesartan—AGTR1—endothelium—metabolic syndrome X	0.00235	0.0673	CbGeAlD
Irbesartan—Epigastric discomfort—Metformin—metabolic syndrome X	0.00219	0.0351	CcSEcCtD
Irbesartan—AGTR1—blood vessel—metabolic syndrome X	0.00216	0.0621	CbGeAlD
Irbesartan—Respiratory distress—Metformin—metabolic syndrome X	0.00182	0.0291	CcSEcCtD
Irbesartan—Heartburn—Metformin—metabolic syndrome X	0.00168	0.0268	CcSEcCtD
Irbesartan—UGT1A3—liver—metabolic syndrome X	0.0014	0.0402	CbGeAlD
Irbesartan—JUN—cardiovascular system—metabolic syndrome X	0.00128	0.0368	CbGeAlD
Irbesartan—JUN—kidney—metabolic syndrome X	0.00125	0.036	CbGeAlD
Irbesartan—EDNRA—adipose tissue—metabolic syndrome X	0.00124	0.0355	CbGeAlD
Irbesartan—PTGS1—artery—metabolic syndrome X	0.00122	0.035	CbGeAlD
Irbesartan—JUN—adipose tissue—metabolic syndrome X	0.00113	0.0324	CbGeAlD
Irbesartan—Lightheadedness—Metformin—metabolic syndrome X	0.00103	0.0165	CcSEcCtD
Irbesartan—PTGS1—endothelium—metabolic syndrome X	0.00103	0.0296	CbGeAlD
Irbesartan—Ear pain—Metformin—metabolic syndrome X	0.000981	0.0157	CcSEcCtD
Irbesartan—AGTR1—cardiovascular system—metabolic syndrome X	0.000965	0.0277	CbGeAlD
Irbesartan—PTGS1—blood vessel—metabolic syndrome X	0.000951	0.0273	CbGeAlD
Irbesartan—AGTR1—kidney—metabolic syndrome X	0.000944	0.0271	CbGeAlD
Irbesartan—Injury—Metformin—metabolic syndrome X	0.000911	0.0146	CcSEcCtD
Irbesartan—Renal impairment—Metformin—metabolic syndrome X	0.00088	0.0141	CcSEcCtD
Irbesartan—AGTR1—adipose tissue—metabolic syndrome X	0.000851	0.0244	CbGeAlD
Irbesartan—JUN—liver—metabolic syndrome X	0.000793	0.0227	CbGeAlD
Irbesartan—Liver function test abnormal—Metformin—metabolic syndrome X	0.000773	0.0124	CcSEcCtD
Irbesartan—Abdominal pain upper—Metformin—metabolic syndrome X	0.000765	0.0122	CcSEcCtD
Irbesartan—Breast disorder—Metformin—metabolic syndrome X	0.000756	0.0121	CcSEcCtD
Irbesartan—Cramp muscle—Metformin—metabolic syndrome X	0.000754	0.0121	CcSEcCtD
Irbesartan—Nasopharyngitis—Metformin—metabolic syndrome X	0.000749	0.012	CcSEcCtD
Irbesartan—Abdominal distension—Metformin—metabolic syndrome X	0.000728	0.0117	CcSEcCtD
Irbesartan—Influenza—Metformin—metabolic syndrome X	0.000723	0.0116	CcSEcCtD
Irbesartan—Pancreatitis—Metformin—metabolic syndrome X	0.000709	0.0114	CcSEcCtD
Irbesartan—Angina pectoris—Metformin—metabolic syndrome X	0.000705	0.0113	CcSEcCtD
Irbesartan—Neutropenia—Metformin—metabolic syndrome X	0.000677	0.0108	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000672	0.0108	CcSEcCtD
Irbesartan—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00061	0.00977	CcSEcCtD
Irbesartan—AGTR1—liver—metabolic syndrome X	0.000597	0.0171	CbGeAlD
Irbesartan—Bradycardia—Metformin—metabolic syndrome X	0.00059	0.00944	CcSEcCtD
Irbesartan—Rhinitis—Metformin—metabolic syndrome X	0.000581	0.0093	CcSEcCtD
Irbesartan—Hepatitis—Metformin—metabolic syndrome X	0.000579	0.00927	CcSEcCtD
Irbesartan—Hypoaesthesia—Metformin—metabolic syndrome X	0.000576	0.00923	CcSEcCtD
Irbesartan—Oedema peripheral—Metformin—metabolic syndrome X	0.00057	0.00914	CcSEcCtD
Irbesartan—Connective tissue disorder—Metformin—metabolic syndrome X	0.000569	0.00911	CcSEcCtD
Irbesartan—Cardiac disorder—Metformin—metabolic syndrome X	0.000537	0.00861	CcSEcCtD
Irbesartan—Flushing—Metformin—metabolic syndrome X	0.000537	0.00861	CcSEcCtD
Irbesartan—Angiopathy—Metformin—metabolic syndrome X	0.000525	0.00841	CcSEcCtD
Irbesartan—Immune system disorder—Metformin—metabolic syndrome X	0.000523	0.00838	CcSEcCtD
Irbesartan—Mediastinal disorder—Metformin—metabolic syndrome X	0.000522	0.00836	CcSEcCtD
Irbesartan—Chills—Metformin—metabolic syndrome X	0.00052	0.00832	CcSEcCtD
Irbesartan—CYP2C8—kidney—metabolic syndrome X	0.000512	0.0147	CbGeAlD
Irbesartan—Losartan—ACE—metabolic syndrome X	0.000504	0.445	CrCbGaD
Irbesartan—Erythema—Metformin—metabolic syndrome X	0.000504	0.00807	CcSEcCtD
Irbesartan—Malnutrition—Metformin—metabolic syndrome X	0.000504	0.00807	CcSEcCtD
Irbesartan—Flatulence—Metformin—metabolic syndrome X	0.000497	0.00796	CcSEcCtD
Irbesartan—Dysgeusia—Metformin—metabolic syndrome X	0.000494	0.00791	CcSEcCtD
Irbesartan—Muscle spasms—Metformin—metabolic syndrome X	0.000485	0.00776	CcSEcCtD
Irbesartan—Vision blurred—Metformin—metabolic syndrome X	0.000475	0.00761	CcSEcCtD
Irbesartan—Tremor—Metformin—metabolic syndrome X	0.000472	0.00756	CcSEcCtD
Irbesartan—Ill-defined disorder—Metformin—metabolic syndrome X	0.000468	0.00749	CcSEcCtD
Irbesartan—CYP2C9—cardiovascular system—metabolic syndrome X	0.000465	0.0133	CbGeAlD
Irbesartan—Malaise—Metformin—metabolic syndrome X	0.000455	0.00728	CcSEcCtD
Irbesartan—Syncope—Metformin—metabolic syndrome X	0.000452	0.00724	CcSEcCtD
Irbesartan—Loss of consciousness—Metformin—metabolic syndrome X	0.000443	0.0071	CcSEcCtD
Irbesartan—Hypertension—Metformin—metabolic syndrome X	0.000435	0.00697	CcSEcCtD
Irbesartan—Chest pain—Metformin—metabolic syndrome X	0.000429	0.00687	CcSEcCtD
Irbesartan—Myalgia—Metformin—metabolic syndrome X	0.000429	0.00687	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000426	0.00683	CcSEcCtD
Irbesartan—PTGS1—cardiovascular system—metabolic syndrome X	0.000424	0.0122	CbGeAlD
Irbesartan—Discomfort—Metformin—metabolic syndrome X	0.000424	0.00679	CcSEcCtD
Irbesartan—Valsartan—ALB—metabolic syndrome X	0.000423	0.373	CrCbGaD
Irbesartan—PTGS1—kidney—metabolic syndrome X	0.000415	0.0119	CbGeAlD
Irbesartan—Oedema—Metformin—metabolic syndrome X	0.000411	0.00659	CcSEcCtD
Irbesartan—Infection—Metformin—metabolic syndrome X	0.000409	0.00655	CcSEcCtD
Irbesartan—Shock—Metformin—metabolic syndrome X	0.000405	0.00648	CcSEcCtD
Irbesartan—Nervous system disorder—Metformin—metabolic syndrome X	0.000403	0.00646	CcSEcCtD
Irbesartan—Thrombocytopenia—Metformin—metabolic syndrome X	0.000403	0.00645	CcSEcCtD
Irbesartan—Skin disorder—Metformin—metabolic syndrome X	0.0004	0.0064	CcSEcCtD
Irbesartan—Hyperhidrosis—Metformin—metabolic syndrome X	0.000398	0.00637	CcSEcCtD
Irbesartan—Anorexia—Metformin—metabolic syndrome X	0.000392	0.00628	CcSEcCtD
Irbesartan—Hypotension—Metformin—metabolic syndrome X	0.000384	0.00616	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000375	0.006	CcSEcCtD
Irbesartan—PTGS1—adipose tissue—metabolic syndrome X	0.000374	0.0107	CbGeAlD
Irbesartan—Paraesthesia—Metformin—metabolic syndrome X	0.000369	0.00592	CcSEcCtD
Irbesartan—Dyspnoea—Metformin—metabolic syndrome X	0.000367	0.00587	CcSEcCtD
Irbesartan—Somnolence—Metformin—metabolic syndrome X	0.000366	0.00586	CcSEcCtD
Irbesartan—Dyspepsia—Metformin—metabolic syndrome X	0.000362	0.0058	CcSEcCtD
Irbesartan—Decreased appetite—Metformin—metabolic syndrome X	0.000358	0.00573	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000355	0.00569	CcSEcCtD
Irbesartan—Fatigue—Metformin—metabolic syndrome X	0.000355	0.00568	CcSEcCtD
Irbesartan—Constipation—Metformin—metabolic syndrome X	0.000352	0.00563	CcSEcCtD
Irbesartan—CYP3A4—kidney—metabolic syndrome X	0.000347	0.00995	CbGeAlD
Irbesartan—CYP2D6—kidney—metabolic syndrome X	0.000341	0.00979	CbGeAlD
Irbesartan—Feeling abnormal—Metformin—metabolic syndrome X	0.000339	0.00543	CcSEcCtD
Irbesartan—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000336	0.00539	CcSEcCtD
Irbesartan—Urticaria—Metformin—metabolic syndrome X	0.000327	0.00523	CcSEcCtD
Irbesartan—Abdominal pain—Metformin—metabolic syndrome X	0.000325	0.00521	CcSEcCtD
Irbesartan—CYP2C8—liver—metabolic syndrome X	0.000324	0.00929	CbGeAlD
Irbesartan—CYP1A2—liver—metabolic syndrome X	0.000303	0.00869	CbGeAlD
Irbesartan—Asthenia—Metformin—metabolic syndrome X	0.000295	0.00473	CcSEcCtD
Irbesartan—Pruritus—Metformin—metabolic syndrome X	0.000291	0.00466	CcSEcCtD
Irbesartan—CYP2C9—liver—metabolic syndrome X	0.000287	0.00825	CbGeAlD
Irbesartan—Diarrhoea—Metformin—metabolic syndrome X	0.000281	0.00451	CcSEcCtD
Irbesartan—Dizziness—Metformin—metabolic syndrome X	0.000272	0.00436	CcSEcCtD
Irbesartan—Vomiting—Metformin—metabolic syndrome X	0.000262	0.00419	CcSEcCtD
Irbesartan—Rash—Metformin—metabolic syndrome X	0.000259	0.00415	CcSEcCtD
Irbesartan—Dermatitis—Metformin—metabolic syndrome X	0.000259	0.00415	CcSEcCtD
Irbesartan—Headache—Metformin—metabolic syndrome X	0.000258	0.00413	CcSEcCtD
Irbesartan—Nausea—Metformin—metabolic syndrome X	0.000244	0.00391	CcSEcCtD
Irbesartan—CYP3A4—liver—metabolic syndrome X	0.000219	0.00629	CbGeAlD
Irbesartan—CYP2D6—liver—metabolic syndrome X	0.000216	0.00619	CbGeAlD
Irbesartan—Losartan—ALB—metabolic syndrome X	0.000207	0.182	CrCbGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.21e-05	0.000157	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.21e-05	0.000157	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IRS1—metabolic syndrome X	1.21e-05	0.000157	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LPL—metabolic syndrome X	1.2e-05	0.000157	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TRIB3—metabolic syndrome X	1.19e-05	0.000155	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.19e-05	0.000154	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—metabolic syndrome X	1.17e-05	0.000153	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—FABP4—metabolic syndrome X	1.16e-05	0.00015	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—INS—metabolic syndrome X	1.15e-05	0.00015	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—G6PD—metabolic syndrome X	1.15e-05	0.00015	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—G6PD—metabolic syndrome X	1.14e-05	0.000149	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—metabolic syndrome X	1.14e-05	0.000148	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.13e-05	0.000147	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	1.13e-05	0.000146	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NOS3—metabolic syndrome X	1.12e-05	0.000146	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IGF1—metabolic syndrome X	1.12e-05	0.000145	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	1.12e-05	0.000145	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	1.12e-05	0.000145	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	1.12e-05	0.000145	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AKT1—metabolic syndrome X	1.11e-05	0.000144	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LPA—metabolic syndrome X	1.1e-05	0.000143	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GCKR—metabolic syndrome X	1.1e-05	0.000143	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	1.1e-05	0.000143	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GCKR—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LPA—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NAMPT—metabolic syndrome X	1.07e-05	0.000139	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	1.07e-05	0.000139	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.07e-05	0.000139	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GCK—metabolic syndrome X	1.06e-05	0.000139	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—LIPC—metabolic syndrome X	1.06e-05	0.000139	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.06e-05	0.000138	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.06e-05	0.000138	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOC3—metabolic syndrome X	1.06e-05	0.000138	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	1.06e-05	0.000137	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOA5—metabolic syndrome X	1.05e-05	0.000137	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOB—metabolic syndrome X	1.05e-05	0.000137	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	1.05e-05	0.000137	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.05e-05	0.000136	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOA5—metabolic syndrome X	1.05e-05	0.000136	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.03e-05	0.000134	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AGT—metabolic syndrome X	1.03e-05	0.000134	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CETP—metabolic syndrome X	1.03e-05	0.000134	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—metabolic syndrome X	1.03e-05	0.000133	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PLA2G4A—metabolic syndrome X	1.02e-05	0.000133	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.02e-05	0.000132	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.01e-05	0.000132	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—metabolic syndrome X	1.01e-05	0.000132	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—metabolic syndrome X	1.01e-05	0.000131	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LEP—metabolic syndrome X	1.01e-05	0.000131	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—LPL—metabolic syndrome X	1.01e-05	0.000131	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AKT1—metabolic syndrome X	1e-05	0.000131	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—metabolic syndrome X	1e-05	0.00013	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOA1—metabolic syndrome X	9.98e-06	0.00013	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	9.95e-06	0.000129	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	9.84e-06	0.000128	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	9.84e-06	0.000128	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	9.81e-06	0.000128	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—G6PD—metabolic syndrome X	9.77e-06	0.000127	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	9.72e-06	0.000126	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	9.64e-06	0.000125	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	9.58e-06	0.000125	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CD36—metabolic syndrome X	9.56e-06	0.000124	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	9.55e-06	0.000124	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	9.54e-06	0.000124	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LPA—metabolic syndrome X	9.32e-06	0.000121	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GCKR—metabolic syndrome X	9.32e-06	0.000121	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	9.29e-06	0.000121	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT2—metabolic syndrome X	9.29e-06	0.000121	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—AKT1—metabolic syndrome X	9.24e-06	0.00012	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	9.03e-06	0.000117	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IRS1—metabolic syndrome X	9.01e-06	0.000117	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	8.96e-06	0.000117	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOA5—metabolic syndrome X	8.94e-06	0.000116	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—FABP4—metabolic syndrome X	8.92e-06	0.000116	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARA—metabolic syndrome X	8.89e-06	0.000116	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	8.8e-06	0.000114	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LIPC—metabolic syndrome X	8.74e-06	0.000114	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GCK—metabolic syndrome X	8.74e-06	0.000114	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	8.72e-06	0.000113	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOC3—metabolic syndrome X	8.69e-06	0.000113	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	8.68e-06	0.000113	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.68e-06	0.000113	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	8.67e-06	0.000113	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GCK—metabolic syndrome X	8.67e-06	0.000113	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LIPC—metabolic syndrome X	8.67e-06	0.000113	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—INS—metabolic syndrome X	8.63e-06	0.000112	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOC3—metabolic syndrome X	8.61e-06	0.000112	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AGT—metabolic syndrome X	8.61e-06	0.000112	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—metabolic syndrome X	8.54e-06	0.000111	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—metabolic syndrome X	8.53e-06	0.000111	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	8.51e-06	0.000111	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—metabolic syndrome X	8.49e-06	0.00011	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	8.46e-06	0.00011	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CETP—metabolic syndrome X	8.43e-06	0.00011	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—metabolic syndrome X	8.43e-06	0.00011	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	8.41e-06	0.000109	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	8.38e-06	0.000109	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CETP—metabolic syndrome X	8.36e-06	0.000109	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF1—metabolic syndrome X	8.35e-06	0.000109	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOA1—metabolic syndrome X	8.33e-06	0.000108	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	8.31e-06	0.000108	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	8.28e-06	0.000108	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	8.28e-06	0.000108	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	8.08e-06	0.000105	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT1—metabolic syndrome X	8.02e-06	0.000104	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT1—metabolic syndrome X	8.02e-06	0.000104	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	8.01e-06	0.000104	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SERPINE1—metabolic syndrome X	7.93e-06	0.000103	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AKT1—metabolic syndrome X	7.88e-06	0.000103	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	7.84e-06	0.000102	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	7.8e-06	0.000101	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	7.77e-06	0.000101	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT2—metabolic syndrome X	7.63e-06	9.92e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	7.63e-06	9.92e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—metabolic syndrome X	7.57e-06	9.84e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	7.56e-06	9.84e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT2—metabolic syndrome X	7.56e-06	9.84e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—G6PD—metabolic syndrome X	7.54e-06	9.81e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	7.45e-06	9.69e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	7.41e-06	9.64e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LIPC—metabolic syndrome X	7.4e-06	9.63e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GCK—metabolic syndrome X	7.4e-06	9.63e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	7.36e-06	9.58e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOC3—metabolic syndrome X	7.36e-06	9.57e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARG—metabolic syndrome X	7.34e-06	9.55e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—INS—metabolic syndrome X	7.2e-06	9.37e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LPA—metabolic syndrome X	7.19e-06	9.36e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GCKR—metabolic syndrome X	7.19e-06	9.36e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CETP—metabolic syndrome X	7.14e-06	9.29e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	6.97e-06	9.06e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA5—metabolic syndrome X	6.9e-06	8.97e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	6.84e-06	8.9e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.82e-06	8.87e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOB—metabolic syndrome X	6.8e-06	8.85e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	6.8e-06	8.84e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	6.8e-06	8.84e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	6.74e-06	8.77e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	6.74e-06	8.77e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—metabolic syndrome X	6.7e-06	8.71e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	6.66e-06	8.67e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	6.64e-06	8.64e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	6.62e-06	8.61e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—metabolic syndrome X	6.6e-06	8.59e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT1—metabolic syndrome X	6.58e-06	8.56e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT1—metabolic syndrome X	6.58e-06	8.56e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT1—metabolic syndrome X	6.53e-06	8.49e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT1—metabolic syndrome X	6.53e-06	8.49e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—LPL—metabolic syndrome X	6.5e-06	8.45e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	6.46e-06	8.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT2—metabolic syndrome X	6.46e-06	8.41e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—metabolic syndrome X	6.43e-06	8.37e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	6.41e-06	8.34e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—metabolic syndrome X	6.32e-06	8.22e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CD36—metabolic syndrome X	6.17e-06	8.03e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AKT1—metabolic syndrome X	5.93e-06	7.72e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—metabolic syndrome X	5.83e-06	7.59e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.83e-06	7.58e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—metabolic syndrome X	5.78e-06	7.52e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	5.76e-06	7.49e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	5.76e-06	7.49e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	5.75e-06	7.48e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARA—metabolic syndrome X	5.74e-06	7.47e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LIPC—metabolic syndrome X	5.71e-06	7.43e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GCK—metabolic syndrome X	5.71e-06	7.43e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOC3—metabolic syndrome X	5.68e-06	7.39e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOB—metabolic syndrome X	5.59e-06	7.27e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT1—metabolic syndrome X	5.58e-06	7.26e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT1—metabolic syndrome X	5.58e-06	7.26e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AGT—metabolic syndrome X	5.56e-06	7.23e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOB—metabolic syndrome X	5.54e-06	7.2e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CETP—metabolic syndrome X	5.51e-06	7.17e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—metabolic syndrome X	5.45e-06	7.09e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	5.43e-06	7.07e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	5.39e-06	7.01e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOA1—metabolic syndrome X	5.38e-06	7e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—AKT1—metabolic syndrome X	5.38e-06	7e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LPL—metabolic syndrome X	5.33e-06	6.94e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LPL—metabolic syndrome X	5.29e-06	6.88e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.28e-06	6.87e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AKT1—metabolic syndrome X	5.16e-06	6.71e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	5.13e-06	6.67e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CD36—metabolic syndrome X	5.07e-06	6.59e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—metabolic syndrome X	5.05e-06	6.57e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CD36—metabolic syndrome X	5.02e-06	6.54e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—metabolic syndrome X	5e-06	6.51e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	4.99e-06	6.49e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT2—metabolic syndrome X	4.99e-06	6.49e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARG—metabolic syndrome X	4.74e-06	6.17e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOB—metabolic syndrome X	4.73e-06	6.16e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARA—metabolic syndrome X	4.71e-06	6.13e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARA—metabolic syndrome X	4.67e-06	6.08e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AKT1—metabolic syndrome X	4.66e-06	6.06e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—INS—metabolic syndrome X	4.65e-06	6.05e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	4.6e-06	5.99e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AGT—metabolic syndrome X	4.56e-06	5.94e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AGT—metabolic syndrome X	4.52e-06	5.89e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LPL—metabolic syndrome X	4.52e-06	5.88e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—metabolic syndrome X	4.47e-06	5.82e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.44e-06	5.78e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.44e-06	5.78e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—metabolic syndrome X	4.43e-06	5.77e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOA1—metabolic syndrome X	4.42e-06	5.75e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOA1—metabolic syndrome X	4.38e-06	5.7e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.3e-06	5.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.3e-06	5.6e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CD36—metabolic syndrome X	4.29e-06	5.59e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—metabolic syndrome X	4.27e-06	5.55e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—metabolic syndrome X	4.08e-06	5.31e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARA—metabolic syndrome X	3.99e-06	5.19e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARG—metabolic syndrome X	3.89e-06	5.07e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AGT—metabolic syndrome X	3.87e-06	5.03e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARG—metabolic syndrome X	3.86e-06	5.02e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—INS—metabolic syndrome X	3.82e-06	4.97e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—metabolic syndrome X	3.79e-06	4.93e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—INS—metabolic syndrome X	3.79e-06	4.93e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—metabolic syndrome X	3.77e-06	4.9e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOA1—metabolic syndrome X	3.74e-06	4.87e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	3.73e-06	4.85e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOB—metabolic syndrome X	3.65e-06	4.75e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.55e-06	4.62e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—metabolic syndrome X	3.5e-06	4.56e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.49e-06	4.54e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AKT1—metabolic syndrome X	3.48e-06	4.52e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—metabolic syndrome X	3.47e-06	4.52e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—metabolic syndrome X	3.35e-06	4.36e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—metabolic syndrome X	3.32e-06	4.32e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.31e-06	4.31e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARG—metabolic syndrome X	3.3e-06	4.29e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—INS—metabolic syndrome X	3.24e-06	4.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.08e-06	4.01e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	3.06e-06	3.99e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	3.04e-06	3.95e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.98e-06	3.88e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—metabolic syndrome X	2.97e-06	3.86e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.92e-06	3.8e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AKT1—metabolic syndrome X	2.9e-06	3.78e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.89e-06	3.76e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—metabolic syndrome X	2.84e-06	3.69e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	2.6e-06	3.38e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.55e-06	3.31e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—INS—metabolic syndrome X	2.5e-06	3.25e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.29e-06	2.98e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.19e-06	2.85e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2e-06	2.61e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AKT1—metabolic syndrome X	1.88e-06	2.44e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.54e-06	2e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1.53e-06	1.99e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKT1—metabolic syndrome X	1.3e-06	1.7e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.01e-06	1.31e-05	CbGpPWpGaD
